Cite

HARVARD Citation

    How, J. et al. (n.d.). A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia. Leukemia & lymphoma. 56 (10), pp. 2793-2802. [Online]. 
  
Back to record